medigraphic.com
ISSN 1405-8871 (Print)

2016, Number 1

<< Back Next >>

Aten Fam 2016; 23 (1)

Epidemiological Outlook of the Patient with Uncontrolled Systemic Hypertension in a Family Medicine Unit in Reynosa, Tamaulipas

Román-Vargas JA, Vázquez-Martínez VH, Loera-Morales JI, Cantú-Solís ON, Cervantes-Vázquez DA, Bernabé-Adame CC

Language: Spanish
References: 26
Page: 14-18
PDF size: 406.34 Kb.


ABSTRACT

Objective: to establish the epidemiological profile of uncontrolled hypertensive patients attending the Family Medicine Unit (umf) no. 33, of the Mexican Social Security Institute (imss), in Reynosa, Tamaulipas, Mexico. Methods: observational and descriptive study, as a survey. 245 hypertensive patients were interviewed; blood pressure was taken in two occasions with a 15 minute interval. Results: 58% of the participants had lack of control of blood pressure; 86% were overweight and obesity; smoking habit 7%. 87% followed a high sodium diet and 53% were sedentary. 70% had information about the seriousness of the disease; 11% was a member of a self-help group of overweight, diabetes and hypertension (Sodhi). Monotherapy prevailed in the treatment of uncontrolled hypertension patients, in contrast to combination therapies. Conclusions: the unsuitable control of patients is a result of low efficiency in health care. It is necessary that all patients without control or have a risk factor that would prevent his good control are referred to self-help groups.


REFERENCES

  1. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002–2030. Ann Trop Med Parasitol. 2006;100:481-499.

  2. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med. 2004;1(1):e27.

  3. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study. Lancet. 2010;376:112-23.

  4. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, et al. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study Heart Awareness Days. Int J Cardiol. 2009;132:233-9.

  5. Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000;14(10-11):749-63.

  6. Robitaille C, Dai S, Waters C, Loukine L, Bancej C, Quach S, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. cmaj. 2011;184(1):e49-e56.

  7. Barquera S, Campos-Nonato I, Hernandez-Barrera L, et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Pública Mex. 2010;52(sup I):S63-S71.

  8. Rojas Martinez R, Aguilar-Salinas CA, Jimenez-Corona A, Gomez-Perez FJ. Barquera S, Lazcano-Ponce E. Prevalence of obesity and metabolic syndrome components in Mexican adult without type 2 diabetes or hypertension. Salud Pública Méx. 2012;54:7-12.

  9. Kearny PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.

  10. Norma Oficial Mexicana: nom-030-SSA 2 1999. Para la prevención, tratamiento y control de la hipertension arterial.

  11. imss. Guía de Práctica Clínica Diagnóstico y Tratamiento de la Hipertensión Arterial en el Primer Nivel de Atención. México: Instituto Mexicano del Seguro Social; 2010.

  12. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.

  13. Lindblad U, Ek J, Eckner J, Larsson CHA, Shan G, Rastam L. Prevalence, awareness, treatment, and control of hypertension: Rule of thirds in the Skaraborg project. Scandinavian Journal of Primary Health Care. 2012;30(2):88-94.

  14. Vijayaraghavan M, He G, Stoddard P, Schillinger D. Blood pressure control, hypertension, awareness and treatment in adults with diabetes in the United States-Mexico border region. Rev Panam Salud Publica. 2010;28(3):164-73.

  15. Bersamin A, Stafford RS, Winkleby MA. Predictors of Hypertension Awareness, Treatment, and Control Among Mexican American women and Men. J Gen Intern Med. 2009;24(3):521-7.

  16. Ng N, Carlberg B, Weinehall L, Norberg M. Trends of blood pressure levels and management in Västerbotten County, Sweden, during 1990-2010. Glob Health Action. [Internet] 2012;5. Disponible en: doi: 10.3402/gha.v5i0.18195

  17. Zhang M, Meng Y, Yang Y, Liu Y, Dong C, Xiao J, et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. bmc Public Health. 2011;11:301.

  18. Roumie CL, Ofner S, Ross JS, Arling G, Williams LS, Ordin DL, et al. Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort. Circ Cardiovasc Qual Outcomes. 2011;4(4):399-407.

  19. Chew BH, Mastura I, Shariff-Ghazali S, Lee PY, Cheong At, Ahmad Z, et al. Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009. Cardiovasc Diabetol. [Internet] 2012;11:54. Disponible en: doi: 10.1186/1475-2840-11-54

  20. Thoenes M, Bramlage P, Zhong S, Shang S, Volpe M, Spirk D. Hypertension control and cardiometabolic risk: A Regional Perspective. Cardiol Res Pract. [Internet] 2012. Disponible en: doi: 10.1155/2012/925046

  21. Scholze J, Alegria E, Ferri C, et al. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. bmc Public Health. 2010;10:529.

  22. Bramlage P, Hasford J. Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment- a review. Cardiovasc Diabetol. [Internet] 2009;8:18. Disponible en: doi: 10.1186/1475-2840-8-18

  23. Hernandez-Hernandez R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J, et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (carmela) study. J Hypertens. 2010;28(1):24-34.

  24. Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechere-Bertschi A. 1999-2009 Trends in Prevalence, Unawareness, Treatment and Control of Hypertension in Geneva, Switzerland. PLoS One. [Internet] 2012;7(6):e39877. Disponible en: doi: 10.1371/journal.pone.0039877

  25. Czernichow S, Castetbon K, Salanave B, Vernay M, Barry Y, Batty GD, et al. Determinants of blood pressure treatment and control in obese people: evidence from the general population. J Hypertens. 2012;30(12):2338-44.

  26. On behalf of the Canadian Hypertension Education Program 2011 Canadian Hypertension Education Program recommendations an annual update. Canadian Family Physician. 2011;57(12):1393-7.




2020     |     www.medigraphic.com